RATIONALE: Survivors of acute lung injury (ALI) frequently have substantial depressive symptoms and physical impairment, but the longitudinal epidemiology of these conditions remains unclear. OBJECTIVES: To evaluate the 2-year incidence and duration of depressive symptoms and physical impairment after ALI, as well as risk factors for these conditions. METHODS: This prospective, longitudinal cohort study recruited patients from 13 intensive care units (ICUs) in four hospitals, with follow-up 3, 6, 12, and 24 months after ALI. The outcomes were Hospital Anxiety and Depression Scale depression score greater than or equal to 8 ("depressive symptoms") in patients without a history of depression before ALI, and two or more dependencies in instrumental activities of daily living ("impaired physical function") in patients without baseline impairment. MEASUREMENTS AND MAIN RESULTS: During 2-year follow-up of 186 ALI survivors, the cumulative incidences of depressive symptoms and impaired physical function were 40 and 66%, respectively, with greatest incidence by 3-month follow-up; modal durations were greater than 21 months for each outcome. Risk factors for incident depressive symptoms were education 12 years or less, baseline disability or unemployment, higher baseline medical comorbidity, and lower blood glucose in the ICU. Risk factors for incident impaired physical function were longer ICU stay and prior depressive symptoms. CONCLUSIONS: Incident depressive symptoms and impaired physical function are common and long-lasting during the first 2 years after ALI. Interventions targeting potentially modifiable risk factors (e.g., substantial depressive symptoms in early recovery) should be evaluated to improve ALI survivors' long-term outcomes.
RATIONALE: Survivors of acute lung injury (ALI) frequently have substantial depressive symptoms and physical impairment, but the longitudinal epidemiology of these conditions remains unclear. OBJECTIVES: To evaluate the 2-year incidence and duration of depressive symptoms and physical impairment after ALI, as well as risk factors for these conditions. METHODS: This prospective, longitudinal cohort study recruited patients from 13 intensive care units (ICUs) in four hospitals, with follow-up 3, 6, 12, and 24 months after ALI. The outcomes were Hospital Anxiety and Depression Scale depression score greater than or equal to 8 ("depressive symptoms") in patients without a history of depression before ALI, and two or more dependencies in instrumental activities of daily living ("impaired physical function") in patients without baseline impairment. MEASUREMENTS AND MAIN RESULTS: During 2-year follow-up of 186 ALI survivors, the cumulative incidences of depressive symptoms and impaired physical function were 40 and 66%, respectively, with greatest incidence by 3-month follow-up; modal durations were greater than 21 months for each outcome. Risk factors for incident depressive symptoms were education 12 years or less, baseline disability or unemployment, higher baseline medical comorbidity, and lower blood glucose in the ICU. Risk factors for incident impaired physical function were longer ICU stay and prior depressive symptoms. CONCLUSIONS: Incident depressive symptoms and impaired physical function are common and long-lasting during the first 2 years after ALI. Interventions targeting potentially modifiable risk factors (e.g., substantial depressive symptoms in early recovery) should be evaluated to improve ALI survivors' long-term outcomes.
Authors: Angela M Cheung; Catherine M Tansey; George Tomlinson; Natalia Diaz-Granados; Andrea Matté; Aiala Barr; Sangeeta Mehta; C David Mazer; Cameron B Guest; Thomas E Stewart; Fatma Al-Saidi; Andrew B Cooper; Deborah Cook; Arthur S Slutsky; Margaret S Herridge Journal: Am J Respir Crit Care Med Date: 2006-06-08 Impact factor: 21.405
Authors: David W Dowdy; Oscar Joseph Bienvenu; Victor D Dinglas; Pedro A Mendez-Tellez; Jonathan Sevransky; Carl Shanholtz; Dale M Needham Journal: Crit Care Med Date: 2009-05 Impact factor: 7.598
Authors: G R Bernard; A Artigas; K L Brigham; J Carlet; K Falke; L Hudson; M Lamy; J R Legall; A Morris; R Spragg Journal: Am J Respir Crit Care Med Date: 1994-03 Impact factor: 21.405
Authors: Mark Unroe; Jeremy M Kahn; Shannon S Carson; Joseph A Govert; Tereza Martinu; Shailaja J Sathy; Alison S Clay; Jessica Chia; Alice Gray; James A Tulsky; Christopher E Cox Journal: Ann Intern Med Date: 2010-08-03 Impact factor: 25.391
Authors: Margaret S Herridge; Angela M Cheung; Catherine M Tansey; Andrea Matte-Martyn; Natalia Diaz-Granados; Fatma Al-Saidi; Andrew B Cooper; Cameron B Guest; C David Mazer; Sangeeta Mehta; Thomas E Stewart; Aiala Barr; Deborah Cook; Arthur S Slutsky Journal: N Engl J Med Date: 2003-02-20 Impact factor: 91.245
Authors: Emilio Sacanella; Joan Manel Pérez-Castejón; Josep Maria Nicolás; Ferran Masanés; Marga Navarro; Pedro Castro; Alfonso López-Soto Journal: Intensive Care Med Date: 2008-11-04 Impact factor: 17.440
Authors: David W Dowdy; Victoriano Dinglas; Pedro A Mendez-Tellez; O Joseph Bienvenu; Jonathan Sevransky; Cheryl R Dennison; Carl Shanholtz; Dale M Needham Journal: Crit Care Med Date: 2008-10 Impact factor: 7.598
Authors: S Jean Hsieh; Graciela J Soto; Aluko A Hope; Ana Ponea; Michelle N Gong Journal: Am J Respir Crit Care Med Date: 2015-01-01 Impact factor: 21.405
Authors: Giora Netzer; David W Dowdy; Thelma Harrington; Satish Chandolu; Victor D Dinglas; Nirav G Shah; Elizabeth Colantuoni; Pedro A Mendez-Tellez; Carl Shanholtz; Jeffrey D Hasday; Dale M Needham Journal: Ann Am Thorac Soc Date: 2013-12
Authors: JiYeon Choi; Jennifer H Lingler; Michael P Donahoe; Mary Beth Happ; Leslie A Hoffman; Judith A Tate Journal: Heart Lung Date: 2018-05-03 Impact factor: 2.210
Authors: Donald F Slack; Douglas S Corwin; Nirav G Shah; Carl B Shanholtz; Avelino C Verceles; Giora Netzer; Kevin M Jones; Clayton H Brown; Michael L Terrin; Jeffrey D Hasday Journal: Crit Care Med Date: 2017-07 Impact factor: 7.598
Authors: Kitty S Chan; Lisa Aronson Friedman; O Joseph Bienvenu; Victor D Dinglas; Brian H Cuthbertson; Richard Porter; Christina Jones; Ramona O Hopkins; Dale M Needham Journal: Gen Hosp Psychiatry Date: 2016-07-12 Impact factor: 3.238
Authors: Elizabeth R Pfoh; Amy W Wozniak; Elizabeth Colantuoni; Victor D Dinglas; Pedro A Mendez-Tellez; Carl Shanholtz; Nancy D Ciesla; Peter J Pronovost; Dale M Needham Journal: Intensive Care Med Date: 2016-09-16 Impact factor: 17.440
Authors: James C Jackson; Pratik P Pandharipande; Timothy D Girard; Nathan E Brummel; Jennifer L Thompson; Christopher G Hughes; Brenda T Pun; Eduard E Vasilevskis; Alessandro Morandi; Ayumi K Shintani; Ramona O Hopkins; Gordon R Bernard; Robert S Dittus; E Wesley Ely Journal: Lancet Respir Med Date: 2014-04-07 Impact factor: 30.700